Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

eFFECTOR Therapeutics Inc. (NASDAQ: EFTR)

 
EFTR Technical Analysis
5
As on 9th Jun 2023 EFTR SHARE Price closed @ 1.38 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.67 & Strong Sell for SHORT-TERM with Stoploss of 6.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EFTRSHARE Price

Open 1.30 Change Price %
High 1.40 1 Day 0.05 3.76
Low 1.29 1 Week 0.45 48.39
Close 1.38 1 Month 0.95 220.93
Volume 2781100 1 Year -7.06 -83.65
52 Week High 9.38 | 52 Week Low 0.34
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
EFTR
Daily Charts		 EFTR
Intraday Charts		 Whats New @
Bazaartrend		 EFTR
Free Analysis
 
EFTR Important Levels Intraday
RESISTANCE1.59
RESISTANCE1.52
RESISTANCE1.48
RESISTANCE1.44
SUPPORT1.32
SUPPORT1.28
SUPPORT1.24
SUPPORT1.17
 
EFTR Forecast April 2024
Share
4th UP Forecast7.93
3rd UP Forecast5.83
2nd UP Forecast4.53
1st UP Forecast3.23
1st DOWN Forecast-0.47
2nd DOWN Forecast-1.77
3rd DOWN Forecast-3.07
4th DOWN Forecast-5.17
 
EFTR Weekly Forecast
4th UP Forecast5.16
3rd UP Forecast3.95
2nd UP Forecast3.20
1st UP Forecast2.45
1st DOWN Forecast0.31
2nd DOWN Forecast-0.44
3rd DOWN Forecast-1.19
4th DOWN Forecast-2.40
 
EFTR Forecast2024
4th UP Forecast19.11
3rd UP Forecast13.42
2nd UP Forecast9.91
1st UP Forecast6.39
1st DOWN Forecast-3.63
2nd DOWN Forecast-7.15
3rd DOWN Forecast-10.66
4th DOWN Forecast-16.35
 
 
EFTR Other Details
Segment EQ
Market Capital 405067232.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EFTR Address
EFTR
 
EFTR Latest News
 
Your Comments and Response on eFFECTOR Therapeutics Inc.
 
EFTR Business Profile
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California. Address:
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service